Literature DB >> 26663677

Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression.

H Anzai1, K Hata1, J Kishikawa1, H Ishii1, T Nishikawa1, T Tanaka1, J Tanaka1, T Kiyomatsu1, K Kawai1, H Nozawa1, S Kazama1, H Yamaguchi1, S Ishihara1, E Sunami1, J Kitayama1, T Watanabe1.   

Abstract

AIM: The rate of extension of proctitis in Western countries has been reported, but no data regarding long-term follow-up have been described for the Japanese population. Additionally, patients with long-standing or extensive ulcerative colitis have an increased risk for developing colorectal cancer. This study evaluated both the rate of extension of the disease and the development of neoplasia among patients with an initial diagnosis of ulcerative proctitis.
METHOD: We retrospectively investigated the medical charts of patients with proctitis from 1979 to 2014. The primary focus of this research was the extension of the inflammatory area. The secondary focus included risk factors for disease extension and the development of neoplasia.
RESULTS: Sixty-six patients satisfied the inclusion criteria. Proximal extension of the disease occurred in 34 patients: 19 patients had left-sided colitis and 15 had pancolitis. According to a multivariate analysis, disease extension was significantly higher in patients with disease onset before 25 years of age (P-value = 0.043). The cumulative rates of disease extension at 10 and 20 years were 33.8% and 52.2%, respectively. Three patients were diagnosed with dysplasia during follow-up, all of whom experienced disease extension before the development of dysplasia.
CONCLUSION: The rate of extension of ulcerative colitis in the Japanese population was comparable to that in Western countries. A younger age of disease onset was associated with disease extension. Extension of proctitis may be associated with an increased risk of colorectal cancer. Colorectal Disease
© 2015 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Dysplasia; progression of ulcerative colitis; younger age at symptom onset

Mesh:

Year:  2016        PMID: 26663677     DOI: 10.1111/codi.13237

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis.

Authors:  Emily Walsh; Young Wha Chah; Samantha M Chin; Paul Lochhead; Vijay Yajnik; Vera Denmark; John J Garber; Hamed Khalili
Journal:  Inflamm Bowel Dis       Date:  2017-11       Impact factor: 5.325

2.  Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center.

Authors:  Sandro da Costa Ferreira; Lilian Rose Otoboni Aprile; Rogério Serafim Parra; Marley Ribeiro Feitosa; Gleici de Castro da Silva Perdoná; Omar Féres; José Joaquim Ribeiro da Rocha; Luiz Ernesto de Almeida Troncon
Journal:  Turk J Gastroenterol       Date:  2022-04       Impact factor: 1.555

3.  Time-adjusted average Mayo endoscopic score predicts the risk of disease extent progression in distal ulcerative colitis patients.

Authors:  Jian Wan; Xuan Wang; Yujie Zhang; Xianmin Xue; Hui Jia; Min Wang; Jie Liang; Kaichun Wu
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-05-18

Review 4.  Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries.

Authors:  Taku Kobayashi; Tadakazu Hisamatsu; Yasuo Suzuki; Haruhiko Ogata; Akira Andoh; Toshimitsu Araki; Ryota Hokari; Hideki Iijima; Hiroki Ikeuchi; Yoh Ishiguro; Shingo Kato; Reiko Kunisaki; Takayuki Matsumoto; Satoshi Motoya; Masakazu Nagahori; Shiro Nakamura; Hiroshi Nakase; Tomoyuki Tsujikawa; Makoto Sasaki; Kaoru Yokoyama; Naoki Yoshimura; Kenji Watanabe; Miiko Katafuchi; Mamoru Watanabe; Toshifumi Hibi
Journal:  Intest Res       Date:  2018-04-30

5.  WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11.

Authors:  Shuqin Xing; Yafei Wang; Kaiwen Hu; Fen Wang; Tao Sun; Quanwang Li
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.